IPG Photonics Q3 Revenue Up 15% to $287.5M, EPS $0.47; Q4 Guidance $265M-$295M
IPGP is trading near its 52-week low of $68.27 (6.8% above the low).
Summary
IPG Photonics grew Q3 revenue 15% to $287.5M and more than doubled net income to $20.3M ($0.47 per diluted share), but Q4 guidance of $265M-$295M implies little sequential growth and excludes the pending Lumibird Medical acquisition.
Key Events · Earnings and Guidance · IPGP
-
Q3 Revenue Grows 15% to $287.5M
Revenue rose to $287.5M from $250.8M a year ago, above the midpoint of guidance, with Industrial Solutions up 12% to $239.5M and Advanced Solutions up 33% to $48.0M.
-
Net Income More Than Doubles
GAAP net income was $20.3M, or $0.47 per diluted share, versus $7.5M and $0.18 a year ago; adjusted EPS was $0.61 and adjusted EBITDA $51.5M, up 39%.
-
Gross Margin Boosted by Tariff Refunds
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% included $5.0M in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption.
-
Q4 Guidance Brackets Current Quarter
Q4 2026 revenue is guided to $265M-$295M with adjusted EPS of $0.30-$0.60 and adjusted EBITDA of $33M-$50M; the range assumes no contribution from Lumibird Medical.
Analysis · IPGP · Manufacturing
Revenue of $287.5M beat the midpoint of guidance and rose 15% year over year, while GAAP EPS came in at $0.47 versus $0.18 a year ago and adjusted EPS at $0.61. The margin story is the real change: gross margin of 40.7% included $5.0M of net tariff refunds, and adjusted EBITDA jumped 39% to $51.5M. Against that, the Q4 guide of $265M-$295M brackets the just-reported quarter and assumes no contribution from the pending Lumibird Medical deal, so the growth rate is set to flatten unless the acquisition closes and adds revenue. The $710.7M cash balance plus $215.3M in short-term investments comfortably funds the €300M cash purchase price previously disclosed.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.1% of the 2636 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IPGP was trading at $72.91 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $68.27 to $155.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.